Showing results (11-20 of 133) with videos related to
Sort By:
Pageof 14
Lakartidningen|February 5, 1992
[Knowledge about metabolic capacity is important in drug therapy]G Alván, M L DahlClinical Rheumatology|September 1, 1994
Reduced sulphoxidation capacity in D-penicillamine induced myasthenia gravisP Seideman, R AyeshActa Psychiatrica Scandinavica. Supplementum|January 1, 1978
The pharmacokinetic profile of oxazepamG Alván, I Odar-CederlöfAustralian Family Physician|December 1, 1991
NSAIDs, musculoskeletal disorders and gastrointestinal adverse effectsR Day, P SeidemanBritish Journal of Rheumatology|April 1, 1988
Equianalgesic effects of paracetamol and indomethacin in rheumatoid arthritisP Seideman, A MelanderThe Journal of Rheumatology|April 1, 1989
Pharmacokinetic interactions of penicillamine in rheumatoid arthritisP Seideman, B LindströmEuropean Journal of Clinical Pharmacology|January 1, 1993
On the question of interindividual variations in chloroquine concentrationsU Hellgren, G Alván, M JerlingEuropean Journal of Clinical Pharmacology|January 1, 1995
References used in a drug information centreA Llerena, B Ohman, G AlvánJournal of Internal Medicine|March 1, 1991
Steady-state concentrations and dosage of digoxin in relation to kidney function in hospitalized patients over 70 years of ageA Algotsson, E Sanz, G AlvánPageof 14